Authors
Latest:
An Editor in Chief for Neurology TimesWe are very pleased to welcome Heidi Moawad, MD as the first ever Editor in Chief of our journal, beginning February 1, 2019.
Latest:
Parkinson Medication Adherence is SuboptimalDrugs often involve multiple daily doses with complex dosing regimens, but interventions that have been applied generically to patients with chronic diseases can be applied to these cases as well.
Latest:
Major Research Goals in Treating Neuropsychiatric Symptoms of Parkinson Disease: Neal Hermanowicz, MDThe neurologist at Christus St. Vincent Health System detailed the areas of research dedicated to understanding more about neuropsychiatric symptoms of Parkinson disease and the root causes of the disease. [WATCH TIME: 3 minutes]
Latest:
Maternal Obesity and EpilepsyNew findings may have an impact on reducing the epilepsy disease burden in future generations.
Latest:
TS Alliance E-Webinar SeriesA look into the numerous education series upcoming in 2021 by the Tuberous Sclerosis Alliance
Latest:
Psychogenic Seizure: 5 Strategies to Assess and TreatIs it a seizure or something else? Here are 5 tips to assess and treat psychogenic non-epileptic seizures.
Latest:
Case Study: Siblings With Hypotonia in All LimbsTwo young siblings presented to the pediatric department with mental retardation, developmental delay, ataxia, and nystagmus since birth. What's your diagnosis after reviewing the case?
Latest:
Are We Overdiagnosing ADHD?How best ensure an accurate ADHD diagnosis in the absence of an established gold-standard or neuroimaging test or biomarker?
Latest:
Beyond the Pain: Considering Migraine in Family PlanningMigraine science continues to deepen the understanding of its impact, even beyond the pain and associated symptoms of the individual attacks, better equipping clinicians to meet their patients where they are.
Latest:
Breakthrough Research in Pediatric EpilepsyHighlights of recent pediatric epilepsy research include a minimally invasive surgical procedure and genetic testing.
Latest:
Concussion: Hollywood Spotlights NeuroscienceWhile Hollywood adapts reality to create a good story, it’s worth fact-checking this movie’s science to better clarify chronic traumatic encephalopathy.
Latest:
What’s in a Name? The Seizure Classification Update and What It All MeansThe conventional classification of seizure types needed a makeover. To employ the 2017 ILAE classification, a clinician should follow some general rules.
Latest:
Loss of Consciousness in an Elderly Woman With Prior CVA: What Cause?Here, view results of CT of the head and axial FLAIR and axial diffusion-weighted MRI studies. What is in your differential? What is your diagnosis?
Latest:
Psychosis in Parkinson DiseaseA host of neuropsychiatric disorders are intrinsic to Parkinson disease or occur as a complication of the dopaminergic therapies. Here's what to look for.
Latest:
Neurological Disorders: Language & Behavior IssuesStudies discussed include neuropsychiatric symptoms leading to mild cognitive impairment and gesture comprehension and language in children with autism.
Latest:
Narcolepsy and the FluObservations over the last few years have indicated that an inciting event of narcolepsy may be infection with influenza or vaccination with particular influenza vaccines.
Latest:
A New Tool to Assess Brain Vascular HealthNoninvasive measurements of cerebral hemodynamics and oxygenation can have a significant impact on the assessment of cerebrovascular conditions and can monitor the effects of clinical procedures on brain circulation.
Latest:
3 New Findings on EpilepsyADHD lowers the quality of life in adults with epilepsy; epilepsy is associated with social deprivation and increased risk of venous thromboembolism: details of these recent findings in this slide show.
Latest:
CGRPs: New Help in Migraine Prophylaxis?A new class of injectable monoclonal antibodies directed against calcitonin gene related peptide (CGRP) or its receptor may offer hope to migraineurs who have not found effective prophylactic therapy.
Latest:
9 Natural Supplements for Cognitive ImpairmentWhich vitamins and supplements have shown promise in treating dementia and preventing cognitive decline?
Latest:
Idiopathic Parkinson: Diagnosis of the DeceptiveThe emergence of Ioflupane I 123 Injection (DaTSCAN) provides clinicians with helpful information to differentiate idiopathic Parkinson disease from other diseases.
Latest:
PACAP: Lessons From A Potent Migraine Inducer?PACAP38 is a potent aggravator of migraine, a new study shows. This provides several new potential therapeutic targets -- most prominently a specific PACAP receptor PAC1.
Latest:
Poor Acute Treatment May Lead to Chronic MigraineEfficacy of acute medication matters beyond just treating a single migraine. It may increase the risk of worsened disease.
Latest:
New Type of Chronic Daily Headache in Older Women?This case series appears to identify a new subtype of chronic daily headache in overweight/obese women in their fifties and sixties.
Latest:
Probing Headaches: A Diagnostic Challenge QuizWhat differentiates migraine from underlying intracranial pathology that may require neuroimaging, like tumors, abscesses, aneurysms, or hemorrhages? Test your skills with this 5-question quiz.
Latest:
Chronic Migraine Out of Control Despite Multiple Drug TrialsYour patient asks if a ketogenic diet can reduce her migraines. What will you tell her?
Latest:
Finding Consensus: Treating Myasthenia GravisThe author discusses MG disease classifications as well as treatment goals and treatment adherence.
Latest:
Exenatide for Parkinson Symptoms: Early Results Are PositiveExenatide, a GLP-1 agonist, has been shown to protect neurons. The authors of two small studies of this agent's effects on motor function in Parkinson disease discuss the evidence here.
Latest:
Leveraging Technology to Improve Epilepsy Treatment: Responsive NeurostimulationAn update on responsive neurostimulation, the only implantable, closed-loop device approved for treating seizures.
